Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
-0.080 (-3.49%)
At close: Jun 21, 2024, 4:00 PM
-0.010 (-0.45%)
After-hours: Jun 21, 2024, 7:59 PM EDT

Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $376.62 million. The enterprise value is $698.89 million.

Market Cap 376.62M
Enterprise Value 698.89M

Important Dates

The next estimated earnings date is Tuesday, July 30, 2024, before market open.

Earnings Date Jul 30, 2024
Ex-Dividend Date n/a

Share Statistics

ESPR has 170.42 million shares outstanding. The number of shares has increased by 141.77% in one year.

Shares Outstanding 170.42M
Shares Change (YoY) +141.77%
Shares Change (QoQ) +68.56%
Owned by Insiders (%) 0.52%
Owned by Institutions (%) 68.91%
Float 164.35M

Valuation Ratios

PE Ratio n/a
Forward PE 1.03
PS Ratio 1.64
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio -4.78
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.04
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.22

Current Ratio 2.22
Quick Ratio 1.71
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -0.48

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -33.40%
Return on Capital (ROIC) -13.63%
Revenue Per Employee $957,250
Profits Per Employee -$360,446
Employee Count 240
Asset Turnover 0.89
Inventory Turnover 0.74


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +56.18% in the last 52 weeks. The beta is 0.99, so ESPR's price volatility has been similar to the market average.

Beta (1Y) 0.99
52-Week Price Change +56.18%
50-Day Moving Average 2.28
200-Day Moving Average 1.94
Relative Strength Index (RSI) 40.99
Average Volume (20 Days) 7,923,672

Short Selling Information

The latest short interest is 21.89 million, so 12.84% of the outstanding shares have been sold short.

Short Interest 21.89M
Short Previous Month 24.91M
Short % of Shares Out 12.84%
Short % of Float 13.32%
Short Ratio (days to cover) 3.32

Income Statement

In the last 12 months, ESPR had revenue of $229.74 million and -$86.51 million in losses. Loss per share was -$0.99.

Revenue 229.74M
Gross Profit 188.05M
Operating Income -34.69M
Pretax Income -86.51M
Net Income -86.51M
EBITDA -27.81M
EBIT -27.89M
Loss Per Share -$0.99
Full Income Statement

Balance Sheet

The company has $226.61 million in cash and $548.87 million in debt, giving a net cash position of -$322.26 million or -$1.89 per share.

Cash & Cash Equivalents 226.61M
Total Debt 548.87M
Net Cash -322.26M
Net Cash Per Share -$1.89
Equity / Book Value -294.30M
Book Value Per Share -1.73
Working Capital 201.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.30 million and capital expenditures -$73,000, giving a free cash flow of -$27.38 million.

Operating Cash Flow -27.30M
Capital Expenditures -73,000
Free Cash Flow -27.38M
FCF Per Share -$0.16
Full Cash Flow Statement


Gross margin is 81.85%, with operating and profit margins of -15.10% and -37.65%.

Gross Margin 81.85%
Operating Margin -15.10%
Pretax Margin -37.65%
Profit Margin -37.65%
EBITDA Margin -12.11%
EBIT Margin -12.14%
FCF Margin -11.92%

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -141.77%
Shareholder Yield -141.77%
Earnings Yield -22.97%
FCF Yield -7.27%

Analyst Forecast

The average price target for ESPR is $8.83, which is 299.55% higher than the current price. The consensus rating is "Buy".

Price Target $8.83
Price Target Difference 299.55%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 63.73%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


ESPR has an Altman Z-Score of -4.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.23
Piotroski F-Score 3